Joseph M. Harvey - 21 May 2026 Form 4 Insider Report for COHEN & STEERS, INC. (CNS)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CNS
Reported as of: 21 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2026, 13:37:01 UTC
Prior SEC filing: 23 Mar 2026
Next SEC filing: 17 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian W. Heller, Attorney-in-Fact

Key filing fact

Joseph M. Harvey filed Form 4 for COHEN & STEERS, INC. (CNS) on 22 May 2026.

Key facts

This page summarizes Joseph M. Harvey's Form 4 filing for COHEN & STEERS, INC. (CNS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 May 2026, 13:37.

Change

Previous filing in this sequence was filed on 23 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001299637 Primary reporting owner

Harvey Joseph M

Relationship: Chief Executive Officer, Director
Address: 1166 AVENUE OF THE AMERICAS, NEW YORK
Signature: /s/ Brian W. Heller, Attorney-in-Fact
Signature date: 22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNS transaction

Common Stock

Award

Transaction value
Shares: +1,514
Change %: +0.11%
Price: $0.000000^*
Shares after: 1,339,012
Date: 21 May 2026
Ownership: Direct
Footnotes: F2

CNS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 305,000
Date: 21 May 2026
Ownership: By LLC
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares held in a limited liability company owned by a family trust. Mr. Harvey disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Footnote F2

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.